BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
Client Focus
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
Archives Portfolio
Bryan, Garnier & Co acts as Financial Advisor to Blueberry Therapeutics on its £10 million Series B Fundraising
Advania, 30% investment by VIA Equity & PFA
80% of Kippr acquired by ECIT AS
MakeIt Drift as acquired by Procano AS
Bryan, Garnier & Co acts as Joint Bookrunner on Materialise’s USD45 million Follow–On Equity Offering on Nasdaq
Bryan, Garnier & Co advises TxCell in its strategic review and subsequent EUR72 million sale to Sangamo Therapeutics to create a CAR-Treg leader
Bryan, Garnier & Co acts as Sole Bookrunner on ASIT biotech EUR12 million Convertible Bond Placement
Bryan, Garnier & Co advises Marquetis & Co and its management on a sponsorless operation with Omnes
Private Placement OncoImmunity AS
Bryan, Garnier & Co acts as Co-manager on Canopy Growth’s benchmark CAD600 million Convertible Bond New Issue
1
…
29
30
31
32
33
…
60
Privacy Preference Center
Privacy Preferences